Therapeutic Biologicals: Navigating Challenges and Opportunities

Therapeutic biologicals – including monoclonal antibodies, recombinant proteins, biosimilars, and cell/gene therapies—represent the future of targeted healthcare. As the global pharmaceutical landscape shifts, India is well-positioned to play a pivotal role. But realizing this potential requires addressing key hurdles while leveraging strategic advantages. Manufacturing Complexity & Quality Assurance: Biological products are inherently complex, derived from […]

Sterile Solutions at Scale: India’s Injectable Manufacturing Momentum

India’s pharmaceutical sector is evolving rapidly, and the injectable segment is at the forefront of this transformation. With rising global demand for sterile, high-quality, and cost-efficient injectable products, contract manufacturing of injectables has become a critical enabler for pharma companies worldwide. In this growing space, Windlas Biotech stands out as a trusted injectable manufacturing partner […]